GROUP ONE TRADING, L.P. - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is and the CUSIP is H17182958. A total of 5 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$5,038,290
-30.9%
111,000
-14.5%
0.02%
-26.1%
Q2 2023$7,292,586
+76.6%
129,900
+42.3%
0.02%
+53.3%
Q1 2023$4,129,499
+3.2%
91,300
-7.2%
0.02%
+66.7%
Q4 2022$3,999,960
-57.3%
98,400
-31.4%
0.01%
-50.0%
Q3 2022$9,371,000
-42.1%
143,400
-46.2%
0.02%
-28.0%
Q2 2022$16,195,000
-35.5%
266,500
-33.3%
0.02%0.0%
Q1 2022$25,095,000
-45.3%
399,800
-33.9%
0.02%
-32.4%
Q4 2021$45,839,000
-52.5%
604,900
-29.8%
0.04%
-64.4%
Q3 2021$96,428,000
-29.4%
861,500
+2.1%
0.10%
-37.0%
Q2 2021$136,603,000
+33.4%
843,800
+0.4%
0.16%
+8.6%
Q1 2021$102,439,000
+88.3%
840,700
+136.6%
0.15%
+61.7%
Q4 2020$54,415,000
+2884.9%
355,400
+1530.3%
0.09%
+1466.7%
Q3 2020$1,823,000
+5.1%
21,800
-7.6%
0.01%
-25.0%
Q2 2020$1,734,000
+107.7%
23,600
+19.8%
0.01%
+14.3%
Q1 2020$835,000
-68.2%
19,700
-54.3%
0.01%
-61.1%
Q4 2019$2,625,000
+672.1%
43,100
+419.3%
0.02%
+500.0%
Q3 2019$340,000
-23.9%
8,300
-12.6%
0.00%
-25.0%
Q2 2019$447,000
-51.5%
9,500
-63.2%
0.00%
-60.0%
Q1 2019$922,000
+48.0%
25,800
+18.3%
0.01%
+100.0%
Q4 2018$623,000
-83.1%
21,800
-73.8%
0.01%
-82.8%
Q3 2018$3,690,000
-31.4%
83,200
-9.2%
0.03%
-37.0%
Q2 2018$5,382,000
+114.9%
91,600
+67.2%
0.05%
+84.0%
Q1 2018$2,505,000
+1427.4%
54,800
+682.9%
0.02%
+2400.0%
Q4 2017$164,0007,0000.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2020
NameSharesValueWeighting ↓
BOOTHBAY FUND MANAGEMENT, LLC 225$3,445,0000.13%
GROUP ONE TRADING, L.P. 355,400$54,415,0000.09%
Marathon Trading Investment Management LLC 3,400$521,0000.03%
SIMPLEX TRADING, LLC 413$6,323,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CRISPR THERAPEUTICS AG shareholders